Review Article
Vaccines for TB: Lessons from the Past Translating into Future Potentials
Table 1
Candidate vaccine with emerging protective responses and its brief description.
| TB vaccine | Vaccine details |
| MVA85A [45] | Modified Vaccinia Ankara virus expressing Ag85A |
| VPM1002 [50] | rBCG expressing listeriolysin |
| AdAg85A [89] | Adenovirus expressing Ag85A |
| ΔIKEPLUS [90] | Mycobacterium smegmatis mutant that expresses M. tb esx-3 genes which is capable of inducing central memory responses |
| SO2 [52] | Mutant M. tb strain that has phoP deleted |
| Hybrid 1 + IC31 [91] | Fusion of ESAT-6 and Ag85B in adjuvant IC31 |
| H4 [57] | Ag85B and TB10.4 administered with IC31 or DDA/MPL |
| H56 [58] | Ag85B and ESAT-6 administered with IC31 |
| rBCG30 [92, 93] | 30-kDa major secretory protein of Mycobacterium tuberculosis |
| M72 + AS01/AS02 [94] | Fusion protein of Rv1196 and Rv0125 in AS01 or AS02 adjuvant |
|
|